Vinciguerra A - Search Results

1

Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke.

Valente A, Mariani J, Seminara S, Tettamanti M, Pignataro G, Perego C, Sironi L, Pedata F, Amantea D, Bacigaluppi M, Vinciguerra A, Diamanti S, Viganò M, Santangelo F, Zoia CP, Rodriguez-Menendez V, Castiglioni L, Rzemieniec J, Dettori I, Bulli I, Coppi E, Di Santo C, Cuomo O, Gullotta GS, Butti E, Bagetta G, Martino G, De Simoni MG, Ferrarese C, Fumagalli S, Beretta S; TRICS study group. Valente A, et al. Among authors: vinciguerra a. J Cereb Blood Flow Metab. 2023 Jul;43(7):1077-1088. doi: 10.1177/0271678X231159958. Epub 2023 Feb 23. J Cereb Blood Flow Metab. 2023. PMID: 36823998 Free PMC article.

2

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.

Cazzola M, Vinciguerra A, Di Perna F, Matera MG. Cazzola M, et al. Among authors: vinciguerra a. Respir Med. 1998 Aug;92(8):1012-6. doi: 10.1016/s0954-6111(98)90347-x. Respir Med. 1998. PMID: 9893768 Free article. Clinical Trial.

3

Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.

Cazzola M, Di Perna F, Califano C, Vinciguerra A, D'Amato M. Cazzola M, et al. Among authors: vinciguerra a. Pulm Pharmacol Ther. 1999;12(4):267-71. doi: 10.1006/pupt.1999.0208. Pulm Pharmacol Ther. 1999. PMID: 10501652 Clinical Trial.

4

Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.

Cazzola M, Calderaro F, Califano C, Di Pema F, Vinciguerra A, Donner CF, Matera MG. Cazzola M, et al. Among authors: vinciguerra a. Eur J Clin Pharmacol. 1999 Jan;54(11):829-33. doi: 10.1007/s002280050561. Eur J Clin Pharmacol. 1999. PMID: 10027655 Clinical Trial.

5

Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.

Cazzola M, Vinciguerra A, Di Perna F, Califano C, Calderaro F, Salzillo A, Centanni S. Cazzola M, et al. Among authors: vinciguerra a. J Chemother. 1999 Apr;11(2):119-25. doi: 10.1179/joc.1999.11.2.119. J Chemother. 1999. PMID: 10326742 Clinical Trial.

6

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Matera MG, Cazzola M, Vinciguerra A, Di Perna F, Calderaro F, Caputi M, Rossi F. Matera MG, et al. Among authors: vinciguerra a. Pulm Pharmacol. 1995 Dec;8(6):267-71. doi: 10.1006/pulp.1995.1036. Pulm Pharmacol. 1995. PMID: 8819181 Clinical Trial.

7

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.

Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. Cazzola M, et al. Among authors: vinciguerra a. Respir Med. 1998 Feb;92(2):354-7. doi: 10.1016/s0954-6111(98)90121-4. Respir Med. 1998. PMID: 9616538 Free article. Clinical Trial.

8

[Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].

Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A. Cazzola M, et al. Among authors: vinciguerra a. Minerva Med. 1998 Jan-Feb;89(1-2):15-22. Minerva Med. 1998. PMID: 9561021 Italian.

9

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.

Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D'Amato G. Cazzola M, et al. Among authors: vinciguerra a. Respir Med. 1995 May;89(5):357-62. doi: 10.1016/0954-6111(95)90008-x. Respir Med. 1995. PMID: 7638371 Free article. Clinical Trial.

10

Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.

Cazzola M, Vinciguerra A, Beghi GF, Paizis G, Giura R, Madonini V, Fiorentini F, Consigli GF, Tonna M, Casalini A, et al. Cazzola M, et al. Among authors: vinciguerra a. J Chemother. 1995 Oct;7(5):432-41. doi: 10.1179/joc.1995.7.5.432. J Chemother. 1995. PMID: 8596127 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page